杆菌感染与结肠直肠癌没有因果关系:一项两样本的孟德尔随机化研究
Shuanhu Wang1, Yakui Liu1, Yi Shi1
1Department of Gastrointestinal surgery, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China.
Asian Pacific journal of cancer prevention : APJCP
|July 29, 2025
概括
杆菌感染与欧洲人的结直肠癌 (CRC) 风险没有因果关系. 这项门德尔随机化研究没有发现任何显著的关联,澄清了H. pylori-CRC关系.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 流行病学 流行病学
背景情况:
- 观察性研究表明,Helicobacter pylori (H. pylori) 感染和结肠直肠癌 (CRC) 之间存在联系.
- 感染H. pylori和CRC之间的因果关系需要进行严格的评估.
- 以前的研究表明存在潜在的关联,需要进一步调查.
研究的目的:
- 在欧洲人口中调查H. pylori感染和CRC之间的因果关系.
- 为了确定H. pylori感染是否会增加患结肠直肠癌的风险.
- 为提供基于证据的洞察力,了解H. pylori-CRC连接.
主要方法:
- 进行了两样本的孟德尔随机化 (MR) 分析.
- 与抗H.pyloriIgG水平相关的遗传变异被用作仪器变量.
- 逆方差加权 (IVW) 分析是主要方法,加权中位数,加权模式和MR-Egger用于灵敏度分析.
主要成果:
- 在所有MR方法中,在抗H. pyloriIgG水平和CRC之间没有发现显著的因果关系.
- 逆方差加权 (IVW) 分析显示没有因果关系 (P = 0.7945).
- 灵敏度分析表明没有显著的异质性或水平性.
结论:
- 在欧洲人群中,H. pylori感染似乎没有显著影响结直肠癌的风险.
- 这些发现表明,H. pylori不太可能是CRC的因果因素.
- 这项研究提供了强有力的证据,反对H. pylori在CRC发展中的因果作用.
更多相关视频
09:05High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability
Published on: November 21, 2014
15.4K
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
494
相关概念视频
01:30Peptic Ulcer Disease I: Introduction
292
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
292
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
549
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
549
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
713
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
713
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
580
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
580
01:17Gastritis-II: Pathophysiology
556
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
556
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
202
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
202